Daxor Corporation (NASDAQ:DXR) Short Interest Down 34.7% in September

Posted by Wayne Rhoads on Oct 8th, 2025

Daxor Corporation (NASDAQ:DXR – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 25,000 shares, a drop of 34.7% from the August 31st total of 38,300 shares. Based on an average trading volume of 28,000 shares, the days-to-cover ratio is presently 0.9 days. Currently, 1.2% of the company’s shares are sold short. Currently, 1.2% of the company’s shares are sold short. Based on an average trading volume of 28,000 shares, the days-to-cover ratio is presently 0.9 days.

Daxor Price Performance

DXR opened at $13.45 on Wednesday. The company has a 50-day moving average of $11.33 and a 200-day moving average of $9.45. Daxor has a 1-year low of $6.55 and a 1-year high of $14.00.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Daxor stock. Osaic Holdings Inc. bought a new stake in shares of Daxor Corporation (NASDAQ:DXR – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,750 shares of the company’s stock, valued at approximately $86,000. Osaic Holdings Inc. owned 0.18% of Daxor as of its most recent SEC filing. Institutional investors and hedge funds own 1.34% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Daxor in a report on Saturday, September 27th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Daxor presently has an average rating of “Moderate Buy” and an average target price of $25.00.

View Our Latest Research Report on DXR

Daxor Company Profile

(Get Free Report)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.